SCHEMBL6349486

SCHEMBL6349486

O=CCP(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 4/20 0.36
CYP2A6 P11509 1/20 0.36
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH7 P40394 1/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 2/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
TRPA1 O75762 1/20 0.31
ALOX5 P09917 1/20 0.31
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL30826334 0.98 TDP1 (0.38) TDP1CYP3A4ALDH1A1CYP2A6ADH1B
SCHEMBL4972429 0.79 CYP3A4 (0.43) TDP1CYP3A4ESR1ESR2
SCHEMBL1038657 0.76 CYP3A4 (0.36) TDP1CYP3A4ALDH1A1CYP2A6ADH1B
SCHEMBL27893167 0.75 CYP3A4 (0.39) TDP1CYP3A4ESR1ESR2
SCHEMBL381091 0.75 CYP3A4 (0.39) TDP1CYP3A4ALDH1A1ESR1ESR2
SCHEMBL8104110 0.75 CYP3A4 (0.39) TDP1CYP3A4ESR1ESR2
SCHEMBL8154471 0.75 CYP3A4 (0.39) TDP1CYP3A4ESR1ESR2
SCHEMBL10975182 0.75 CYP3A4 (0.35) TDP1CYP3A4
Formaldehyde SCHEMBL11418512 0.75 CYP3A4 (0.35) TDP1CYP3A4ALDH1A1LMNA
Iodide SCHEMBL28416673 0.75 CYP3A4 (0.35) TDP1CYP3A4ALDH1A1CYP2A6ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135698-B Process for producing cyclic polysiloxane 信越化学工业株式会社 2024-04-26 CN disclosed
CN-115135698-A Method for producing cyclic polysiloxane 信越化学工业株式会社 2022-09-30 CN disclosed
CN-107709322-B Tricyclic compounds as anticancer agents 百时美施贵宝公司 2021-05-07 CN disclosed
US-9597673-B2 Iron catalysts with unsymmetrical PNN'P ligands THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2017-03-21 US disclosed
CN-106165175-A High molecular electrolyte composition and use its polyelectrolyte membrane, film electrode composite element and polymer electrolyte fuel cell 东丽株式会社 2016-11-23 CN disclosed
US-20150151289-A1 IRON CATALYSTS WITH UNSYMMETRICAL PNN'P LIGANDS GOVERING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2015-06-04 US disclosed
US-20140243543-A1 IRON(II) CATALYSTS CONTAINING DIIMINO-DIPHOSPHINE TETRADENTATE LIGANDS AND THEIR SYNTHESIS THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2014-08-28 US disclosed
US-7642366-B2 Phosphine ligands HOFFMANN-LA ROCHE INC. (US) 2010-01-05 US disclosed
US-20090326253-A1 NOVEL PHOSPHINE LIGANDS IDING HANS 2009-12-31 US disclosed
US-6963005-B2 Compounds comprising phosphorus-containing metal complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2005-11-08 US disclosed
CN-1117115-C Copper bromide polymer, its synthesis method and its application INST OF CHEMISTRY HE NAN PROV (CN) 2003-08-06 CN disclosed
CN-1072967-C Uncomplexed cyclodextrin solutions for odor control or inanimate surface PROCTER & GAMBLES CO (US) 2001-10-17 CN disclosed
CN-1257859-A Process for preparing 3-pentenic acid from allyl butenyl alcohol or ester using nickel catalyst DU PONT (US) 2000-06-28 CN disclosed
US-6015923-A REACTING ALCOHOL OR ESTER WITH CARBON MONOXIDE IN PRESENCE OF NICKEL AND IODIDE SOURCE IN CARBOXYLIC ACID SOLVENT UNDER SPECIFIED CONDITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-01-18 US disclosed
CN-1161002-A Composition for reducing malodor impression on inanimate surfaces PROCTER & GAMBLE (US) 1997-10-01 CN disclosed
CN-1159762-A Uncomplexed cyclodextrin solutions for odor control or inanimate surface PROCTER & GAMBLE (US) 1997-09-17 CN disclosed
EP-0340391-B1 1,4-Disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides CANADA CYANAMID (CA) 1994-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150151289-A1 IRON CATALYSTS WITH UNSYMMETRICAL PNN'P LIGANDS PNN, NCL, IDH2 TDP1 2154/4885CYP3A4 1727/4885ALDH1A1 1384/4885
US-20090326253-A1 NOVEL PHOSPHINE LIGANDS PRMT8, GRB7, STK38L TDP1 4580/4885CYP3A4 1963/4885ALDH1A1 4347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.